市場調查報告書
商品編碼
1123192
手術用密封膠的全球市場(2022年~2028年)Global Surgical Sealants Market Research and Forecast 2022-2028 |
全球手術用密封膠的市場規模,在預測期間內預計以9.7%的年複合成長率成長。由於主要手術用密封膠的優點相關的意識的高漲,及美國的成人的久坐生活方式與不完善的飲食習慣造成的手術增加,促進市場成長。
本報告提供全球手術用密封膠市場相關調查分析,市場區隔分析,地區分析,預測,企業簡介等資訊。
Global Surgical Sealants Market Size, Share & Trends Analysis Report by Type (Natural or Biological Sealants, and Synthetic and Semi-Synthetic Sealants), By Indications (Surgical Hemostasis, Tissue Sealing, and Tissue Engineering), By Applications (Central Nervous System (CNS) Surgeries, General Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Cosmetic Surgeries, Urological Surgery, Pulmonary Surgeries, and Others (Ophthalmic Surgeries) By End User (Hospitals, Clinics, and Ambulatory Surgical Centers) Forecast, 2021-2027
The global surgical sealants market is anticipated to grow at a CAGR of 9.7% during the forecast period. Surgical sealants are used to repair elastic and soft tissue such as wounded injury, lungs, and heart among others. It prevents the leakage of the tissue by binding them together, internally and externally, during injury or post-surgery. The sealant products are made from natural or synthetic materials such as gelatin, fibrin, albumin, and polyethylene glycol (PEG) polymers. Surgical sealants and adhesives have significantly been used over conventional approaches used for wound closure such as staples and sutures. Surgical sealants have increasingly being adopted by surgeons in cardiovascular surgery, pulmonary surgery, orthopedic surgery, and ophthalmic surgery, among others. The various advantages associated with surgical sealants such as safety, easy usability, and efficacy in several conditions in different tissues. Moreover, it promotes wound healing and significantly removes the requirement of sutures and staples.
The increasing awareness of the benefits of surgical sealants in surgical procedure, and the rising number of surgical procedures due to the sedentary lifestyle and faulty dietary habits of the adult population in the US is majorly propelling the growth of the global surgical sealants market. Besides, the rising prevalence of chronic disease, the number of surgeries has increased as most of the chronic diseases in later stages demand surgeries. For instance, as per Dementia Australia, around 459,000 Australians were living with dementia in 2020, and about 1.6 million were involved in their center for care. It is estimated to reach 1.1 million by 2058.
The high cost associated with surgical sealants and adhesives in the low- and middle-income economies is the major factor restraining the growth of the global surgical sealants market. The side effects associated with the sealants and adhesives, stringent regulatory policies, low surgical incision closure strength, and availability of cheaper alternative products such as sutures and staples are some of the factors limiting the growth of the global surgical sealants market. However, the rising prevalence of chronic diseases such as cancer and heart diseases, a significant increase in the number of FDA approvals, and increasing investments by major players in emerging economies are likely to fuel the market growth in the near future.
Impact of COVID-19 Pandemic on Global Surgical Sealants Market
The global surgical sealants market is hardly hit by the COVID-19 pandemic since December 2019. The pandemic has had an impact on how people function and how different surgical procedures are performed. For surgeons to continue to provide safe and appropriate treatment to their patients during the COVID-19 pandemic, stringent guidelines specific to each specialty must be enforced and followed. The number of surgeries has significantly declined during the pandemic, due to the strict guidelines by the regulatory authorities to avoid all non-emergent surgeries. This would have an impact on the procurement of surgical sealants and adhesives in surgical centers. The outbreak of COVID-19 has disrupted the supply of raw materials and products across the globe, hence impacted the surgical sealants market negatively. To fight the pandemic the key players were focusing on the manufacturing of chemicals for sanitizers, and also donated methylene diphenyl diisocyanate (MDI) to enable the manufacture of prefabricated polyurethane insulation panels for hospital construction and other materials to manufacture personal protective equipment (PPE) for medical personnel fighting the coronavirus. The market will witness "V" shape recovery in near future owing to the restart of key industries in major economies.
Segmental Outlook
The global surgical sealants market is segmented based on type, indication, application, and end-user. Based on the type, the market is segmented into natural or biological sealants and synthetic and semi-synthetic sealants. Further, the natural or biological sealants are segmented into fibrin sealants, collagen-based adhesives, and gelatin-based adhesives. The synthetic and semi-synthetic sealants are segmented into cyanoacrylates, polymeric hydrogels, and others (polyethylene glycol polymer). Based on the indication, the market is segmented into surgical hemostasis, tissue sealing, and tissue engineering. Based on the application, the market is segmented into central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, urological surgery, pulmonary surgeries, and others. Besides, based on the end-user, the market is segmented into hospitals, clinics, and ambulatory surgical centers.
Global Surgical Sealants Market Share by Type, 2020 (%)
Global Surgical Sealants Market Share by Type,
Natural or Biological Sealants Segment holds the significant share in the Market
Among the sealants type, the natural or biological sealants segments held the major share in 2020 and is also anticipated to grow during the forecast period. Natural or biological are further classified into fibrin, collagen-based, and gelatin-based. Fibrin sealants held the largest market share in the year 2020, due to their applications in medical practice. Surgical Sealants effective for various applications include thoracic, cardiovascular surgery, orthopedic surgery, central nervous system (CNS) surgery, general surgery, cosmetics surgery, and reconstructive surgeries. Furthermore, among other sealants, fibrin is the only product to have received approval from the FDA, to be used under all three groups, namely hemostats, sealants, and adhesives. For instance, in September 2018, Baxter International Inc., a medical products company, has acquired hemostat and sealant products from Mallinckrodt plc which include RECOTHROM Thrombin topical (Recombinant), the first and only stand-alone recombinant thrombin, and PREVELEAK Surgical Sealant, which is used in vascular reconstruction, both are fibrin-based products and approved by the US FDA.
Regional Outlook
The global surgical sealants market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America holds a dominant position in the global surgical sealants market in 2020 due to the rise in the number of surgeries along with the wide availability of modern medical technology in the region. Moreover, the sedentary lifestyle of the population has significantly increased the surgical procedures in the region, which in turn fuels the market growth in the region.
Global Surgical Sealants Market Growth, by Region 2021-2027
Global Surgical Sealants Market Growth, by Region
Asia-Pacific is projected to have considerable growth in the global surgical sealants market
The Asia-Pacific is projected to exhibit the fastest growth in the global surgical sealants market during the forecast period. This is mainly owing to the presence of a huge pool of patients especially people over 65 years, and increasing healthcare spending by government authorities and individuals. For instance, as per the WHO, in 2018, around 6.8% of GDP was the healthcare expenditure in Asia-pacific. Besides, as per the World Bank, in 2019, around 28% of the Japanese population is more than 65 years. And around 11.47% of the China population is over 65 years. The elderly are at a greater risk of developing chronic disease which required surgery. Thus, rapid development in the healthcare sector is assisting the companies to develop their market in the Asia-Pacific region. Moreover, the refining healthcare infrastructure due to increasing awareness of natural sealants among the population is one of the factors driving the growth of the surgical sealants market in the Asia Pacific.
Market Players Outlook
The key players of the surgical sealants market include Baxter International Inc., B. Braun Melsungen AG, Cohera Medical, Inc., CryoLife Inc., C.R. Bard Inc., CSL Limited (CSL Behring), Johnson & Johnson (Ethicon, Inc.), Ocular Therapeutix Inc., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, geographical expansion, collaborations, and new product launches, to stay competitive in the market. For instance, in January 2019, Advanced Medical Solutions Group plc, the surgical and advanced wound care specialist company, has announced that it has acquired Sealantis Limited, a developer of an alginate-based tissue adhesive technology platform, for around $25 million.
The Report Covers